BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24236820)

  • 1. Medical approaches to non-melanoma skin cancer.
    Micali G; Lacarrubba F; Bhatt K; Nasca MR
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1409-21. PubMed ID: 24236820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical pharmacotherapy for skin cancer: part I. Pharmacology.
    Micali G; Lacarrubba F; Nasca MR; Schwartz RA
    J Am Acad Dermatol; 2014 Jun; 70(6):965.e1-12; quiz 977-8. PubMed ID: 24831324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer.
    Savoia P; Cremona O; Fava P
    Curr Drug Targets; 2016; 17(3):353-74. PubMed ID: 26245477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical pharmacotherapy for skin cancer: part II. Clinical applications.
    Micali G; Lacarrubba F; Nasca MR; Ferraro S; Schwartz RA
    J Am Acad Dermatol; 2014 Jun; 70(6):979.e1-12; quiz 9912. PubMed ID: 24831325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
    Desai T; Chen CL; Desai A; Kirby W
    Dermatol Surg; 2012 Jan; 38(1):97-103. PubMed ID: 22092926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
    Gracia-Cazaña T; González S; Gilaberte Y
    Actas Dermosifiliogr; 2016 Nov; 107(9):730-739. PubMed ID: 27436800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
    Sidoroff A; Thaler P
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.
    van Ruth S; Jansman FG; Sanders CJ
    Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical combination of diclofenac, calcipotriol, and difluoromethylornithine has beneficial effects comparable to 5-fluorouracil for the treatment of non-melanoma skin cancer in mice.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    J Chemother; 2014 Apr; 26(2):105-10. PubMed ID: 24090798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapies for non-melanoma skin cancer.
    Chakrabarty A; Geisse JK
    Clin Dermatol; 2004; 22(3):183-8. PubMed ID: 15262303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab in non-melanoma skin cancer.
    Wollina U
    Expert Opin Biol Ther; 2012 Jul; 12(7):949-56. PubMed ID: 22519406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers.
    Odueyungbo M; Ratner D
    Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of Inflammation in Topical Therapy of Skin Cancers.
    Voiculescu VM; Lisievici CV; Lupu M; Vajaitu C; Draghici CC; Popa AV; Solomon I; Sebe TI; Constantin MM; Caruntu C
    Mediators Inflamm; 2019; 2019():8369690. PubMed ID: 30766448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
    Stockfleth E
    J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancer.
    Mahen KK; Markley L; Bogart J; Klatka H; Krishna V; Maytin EV; Stark GR; McDonald C
    Exp Dermatol; 2023 Sep; 32(9):1485-1497. PubMed ID: 37309615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regional chemotherapy for melanoma metastases.
    Voigt H
    Anticancer Res; 1988; 8(3):347-9. PubMed ID: 2455471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
    Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.